Please see the table below for the list of top 10 US CLO managers and their assets under (US CLO) management (billion) breakdown by reinvestment (RI) period as of 31 August 2022 based on LCD and Intex data.
US CLO Manager | CLO AUM ($ BN) as of 31 Aug 22 | Over 4y | B/w 3 & 4y | B/w 2 & 3y | B/w 1 & 2y | B/w 0 & 1y | Less than 0y |
Carlyle Group | 37.2 | 16.4% | 23.1% | 3.9% | 15.7% | 29.2% | 11.6% |
Blackstone | 33.1 | 22.9% | 24.9% | 0.0% | 9.87% | 19.6% | 16.6% |
Golub Capital | 31.6 | 3.0% | 27.8% | 15.7% | 13.0% | 29.8% | 10.7% |
CSAM | 30.2 | 17.4% | 7.7% | 11.6% | 25.5% | 14.7% | 23.1% |
CIFC Asset Management | 27.4 | 23.6% | 12.8% | 6.4% | 16.1% | 23.9% | 17.2% |
Ares Management | 25.7 | 21.9% | 23.9% | 12.0% | 9.6% | 23.3% | 9.4% |
PGIM | 24.5 | 20.4% | 16.4% | 6.9% | 10.0% | 29.0% | 17.3% |
Octagon Credit Investors | 24.3 | 25.2% | 16.7% | 6.3% | 13.9% | 26.4% | 11.5% |
Neuberger Berman | 18.8 | 24.4% | 16.9% | 14.7% | 21.3% | 15.2% | 7.6% |
KKR Financial Advisors | 18.5 | 20.2% | 18.7% | 7.3% | 13.8% | 20.0% | 20.0% |
Related articles:
Top 100 US CLO Managers: AUM Breakdown by RI Period
(Featured) US CLO Managers: Quarterly Relative Standing Based on MV Return Alpha
Disclaimers
The information, research, data, research related opinions, observations and estimates contained in this document have been compiled or arrived at by CLO Research Group, based upon sources believed to be reliable and accurate, and in good faith, but in each case without further investigation. None of CLO Research Group or its service providers; authorized personnel, or their directors make any expressed or implied presentation or warranty, nor do any of such persons accept any responsibility or liability as to the accuracy, timeliness, completeness or correctness of such sources and the information, research, data, research related opinions, observations and estimates contained in this document. All information, research, data, research related opinions, observations, and estimates in this document are in draft form as of the date of this document and remain subject to change and amendment without notice. Neither CLO Research Group nor any of their third-party providers shall be subject to any damages or liability for any errors, omissions, incompleteness or incorrectness of this document. This article is not and should not be construed as an offer, or a solicitation of an offer, to buy or sell securities and shall not be relied upon as a promise or representation regarding the historical or current position or performance of any of the deals or issues mentioned in it.